← Oncology Approval Tracker

FDA DECISION ·

Cabazitaxel Injection

cabazitaxel · Actavis

FDA approvalNew formulationProstate cancer
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

With prednisone for patients with metastatic castration-resistant prostate cancer previously treated with a docetaxel-containing regimen.

LAMPGEN ANALYSIS

Why it matters

The injection is an alternative cabazitaxel presentation for an established post-docetaxel setting.

What research teams should watch

Verify the formulation and required dilution steps on the specific product, and coordinate myelosuppression monitoring.

PRIMARY RECORDS

Sources